ClearPoint Neuro (CLPT) Amortizatization of Intangibles (2022 - 2023)

ClearPoint Neuro (CLPT) reported Amortizatization of Intangibles of $57000.0 for Q2 2023, up 147.83% on a YoY basis from $23000.0 in Q2 2022, and down 17.39% sequentially from $69000.0 in Q1 2023.

ClearPoint Neuro (CLPT) Amortizatization of Intangibles (2022 - 2023) Analysis & Trends

ClearPoint Neuro (CLPT) has 2 years of Amortizatization of Intangibles data on file, last reported at $57000.0 in Q2 2023.

  • For the quarter ending Q2 2023, Amortizatization of Intangibles rose 147.83% year-over-year to $57000.0; the trailing twelve-month figure through Mar 2024 stood at $57000.0 (down 83.85% YoY), and the FY2023 full-year result was $126000.0, down 55.63% from the prior year.
  • Amortizatization of Intangibles declined to $57000.0 in Q2 2023, from $69000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $136000.0 in Q3 2022 to a low of $23000.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 ClearPoint Neuro 431.98 Mn 396.38 Mn 7.76 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 57,000.00
Jun 30, 2023 57,000.00
Mar 31, 2023 69,000.00
Mar 31, 2023 69,000.00
Dec 31, 2022 125,000.00
Dec 31, 2022 125,000.00
Sep 30, 2022 136,000.00
Sep 30, 2022 136,000.00
Jun 30, 2022 23,000.00
Jun 30, 2022 23,000.00